✦ LIBER ✦

Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation

✍ Scribed by Zhuo, Min; Hu, Yinghe; Schultz, Carsten; Kandel, Eric R.; Hawkins, Robert D.

Book ID: 109788276
Publisher: Nature Publishing Group
Year: 1994
Tongue: English
Weight: 535 KB
Volume: 368
Category: Article
ISSN: 0028-0836
DOI: 10.1038/368635a0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term potentiation in hippocampus in

Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia

✍ Pilar Monfort; Vicente Felipo 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 187 KB

Opposite effects of cGMP-dependent prote

Opposite effects of cGMP-dependent protein kinase on cGMP production by soluble and particular guanylyl cyclase in adult ventricular myocytes

✍ Liliana Castro; Rodolphe Fischmeister 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 192 KB

cGMP-dependent kinase I supports formati

cGMP-dependent kinase I supports formation of associative fear memory and long-term potentiation in the lateral amygdala

✍ Cindy Paul; Pascal Weinmeister; Robert Feil; Franz Hofmann; Thomas Kleppisch 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 432 KB

An essential role for postsynaptic calmo

An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation

✍ Malenka, Robert C.; Kauer, Julie A.; Perkel, David J.; Mauk, Michael D.; Kelly, 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 442 KB

Role of cGMP dependent protein kinases i

Role of cGMP dependent protein kinases in the circadian system

✍ Urs Albrecht; Sonja Langmesser; Henrik Oster; Franz Hoffmann; Robert Feil 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 185 KB

Galantamine enhancement of long-term pot

Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation

✍ Shigeki Moriguchi; Norifumi Shioda; Feng Han; Jay Z. Yeh; Toshio Narahashi; Kohj 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 652 KB

## Abstract Galantamine, a novel Alzheimer's drug, is known to inhibit acetylcholinesterase activity and potentiate nicotinic acetylcholine receptor (nAChR) in the brain. We previously reported that galantamine potentiates the NMDA‐induced currents in primary cultured rat cortical neurons. We now s